Home > Publications database > Determinants of blood acylcarnitine concentrations in healthy individuals of the European Prospective Investigation into Cancer and Nutrition. > print

001     180561
005     20240229145623.0
024 7 _ |a 10.1016/j.clnu.2022.05.020
|2 doi
024 7 _ |a pmid:35779425
|2 pmid
024 7 _ |a 0261-5614
|2 ISSN
024 7 _ |a 1532-1983
|2 ISSN
024 7 _ |a altmetric:129703618
|2 altmetric
037 _ _ |a DKFZ-2022-01406
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Wedekind, Roland
|b 0
245 _ _ |a Determinants of blood acylcarnitine concentrations in healthy individuals of the European Prospective Investigation into Cancer and Nutrition.
260 _ _ |a Amsterdam [u.a.]
|c 2022
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1656925246_30918
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Circulating levels of acylcarnitines (ACs) have been associated with the risk of various diseases such as cancer and type 2 diabetes. Diet and lifestyle factors have been shown to influence AC concentrations but a better understanding of their biological, lifestyle and metabolic determinants is needed.Circulating ACs were measured in blood by targeted (15 ACs) and untargeted metabolomics (50 ACs) in 7770 and 395 healthy participants of the European Prospective Investigation into Cancer and Nutrition (EPIC), respectively. Associations with biological and lifestyle characteristics, dietary patterns, self-reported intake of individual foods, estimated intake of carnitine and fatty acids, and fatty acids in plasma phospholipid fraction and amino acids in blood were assessed.Age, sex and fasting status were associated with the largest proportion of AC variability (partial-r up to 0.19, 0.18 and 0.16, respectively). Some AC species of medium or long-chain fatty acid moiety were associated with the corresponding fatty acids in plasma (partial-r = 0.24) or with intake of specific foods such as dairy foods containing the same fatty acid. ACs of short-chain fatty acid moiety (propionylcarnitine and valerylcarnitine) were moderately associated with concentrations of branched-chain amino acids (partial-r = 0.5). Intake of most other foods and of carnitine showed little association with AC levels.Our results show that determinants of ACs in blood vary according to their fatty acid moiety, and that their concentrations are related to age, sex, diet, and fasting status. Knowledge on their potential determinants may help interpret associations of ACs with disease risk and inform on potential dietary and lifestyle factors that might be modified for disease prevention.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
650 _ 7 |a Acylcarnitines
|2 Other
650 _ 7 |a Branched-chain amino acids
|2 Other
650 _ 7 |a Diet
|2 Other
650 _ 7 |a Fatty acids
|2 Other
650 _ 7 |a Metabolomics
|2 Other
700 1 _ |a Rothwell, Joseph A
|b 1
700 1 _ |a Viallon, Vivian
|b 2
700 1 _ |a Keski-Rahkonen, Pekka
|b 3
700 1 _ |a Schmidt, Julie A
|b 4
700 1 _ |a Chajes, Veronique
|b 5
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 6
|u dkfz
700 1 _ |a Johnson, Theron
|0 P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa
|b 7
700 1 _ |a Santucci de Magistris, Maria
|b 8
700 1 _ |a Krogh, Vittorio
|b 9
700 1 _ |a Amiano, Pilar
|b 10
700 1 _ |a Sacerdote, Carlotta
|b 11
700 1 _ |a Redondo-Sánchez, Daniel
|b 12
700 1 _ |a Huerta, José María
|b 13
700 1 _ |a Tjønneland, Anne
|b 14
700 1 _ |a Pokharel, Pratik
|b 15
700 1 _ |a Jakszyn, Paula
|b 16
700 1 _ |a Tumino, Rosario
|b 17
700 1 _ |a Ardanaz, Eva
|b 18
700 1 _ |a Sandanger, Torkjel M
|b 19
700 1 _ |a Winkvist, Anna
|b 20
700 1 _ |a Hultdin, Johan
|b 21
700 1 _ |a Schulze, Matthias B
|b 22
700 1 _ |a Weiderpass, Elisabete
|b 23
700 1 _ |a Gunter, Marc J
|b 24
700 1 _ |a Huybrechts, Inge
|b 25
700 1 _ |a Scalbert, Augustin
|b 26
773 _ _ |a 10.1016/j.clnu.2022.05.020
|g Vol. 41, no. 8, p. 1735 - 1745
|0 PERI:(DE-600)2009052-3
|n 8
|p 1735 - 1745
|t Clinical nutrition
|v 41
|y 2022
|x 0261-5614
909 C O |o oai:inrepo02.dkfz.de:180561
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 6
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 7
|6 P:(DE-He78)79ab945544e5bc017a2317b6146ed3aa
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2022
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-30
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-30
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2022-11-12
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-12
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b CLIN NUTR : 2021
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-12
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b CLIN NUTR : 2021
|d 2022-11-12
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21